Market Research Report
Cardiac Monitoring & Cardiac Rhythm Management - Global Market Outlook (2016-2022)
|Published by||Stratistics Market Research Consulting||Product code||521564|
|Published||Content info||153 Pages
Delivery time: 1-2 business days
|Cardiac Monitoring & Cardiac Rhythm Management - Global Market Outlook (2016-2022)|
|Published: March 1, 2017||Content info: 153 Pages||
According to Stratistics MRC, the Global Cardiac Monitoring & Cardiac Rhythm Management market is expected to grow from $24.47 billion in 2016 to reach $35.21 billion by 2022 with a CAGR of 6.2%. Growing prevalence of cardiovascular diseases, recent technological developments, and growing investments in research & development activities are the factors propelling the market growth. In addition, favorable government regulations and increasing health care awareness are boosting the market. However, high costs for devices and lack of standard healthcare policies are restraining the market growth.
Among cardiac rhythm management products, defibrillators segment commands the global market due to availability of improved defibrillators, increasing cardiovascular diseases and sudden cardiac arrest. By cardiac monitoring product, ECG Devices segment is expected to dominate the market during the forecast period. Asia Pacific accounted for the largest share of the market attributed to large number of healthcare reforms, high prevalence of heart failures, and growing medical tourism.
Some of the key players in global cardiac monitoring & cardiac rhythm management market include Abiomed, Inc., Berlin Heart Gmbh, Biotronik Se & Co., Kg, Boston Scientific Corporation, Cardiac Science Corporation, GE Healthcare, Jarvik Heart, Inc., Koninklijke Philips N.V., Livanova PLC, Medtronic PLC, Mortara Instrument, Inc., Nihon Kohden Corporation, Philips Healthcare, Reliantheart, Inc., Schiller AG, and St. Jude Medical, Inc.
Cardiac Monitoring Products Covered:
Cardiac Rhythm Management Products Covered:
End Users Covered:
What our report offers: